4//SEC Filing
Rasdal Andrew P 4
Accession 0001214659-17-006344
CIK 0001427570other
Filed
Nov 1, 8:00 PM ET
Accepted
Nov 2, 2:24 PM ET
Size
4.8 KB
Accession
0001214659-17-006344
Insider Transaction Report
Form 4
Rasdal Andrew P
DirectorPresident & CEO
Transactions
- Award
Common Stock
2017-10-31$7.17/sh+808$5,793→ 454,071 total
Footnotes (1)
- [F1]These shares were acquired under the Obalon Therapeutics, Inc. 2016 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Documents
Issuer
OBALON THERAPEUTICS INC
CIK 0001427570
Entity typeother
Related Parties
1- filerCIK 0001323238
Filing Metadata
- Form type
- 4
- Filed
- Nov 1, 8:00 PM ET
- Accepted
- Nov 2, 2:24 PM ET
- Size
- 4.8 KB